| Literature DB >> 31186066 |
K Martin1, S Geuens2, J K Asche3, R Bodan4, F Browne5, A Downe6, N García García7, G Jaega8, B Kennedy5, P J Mauritz9, F Pérez10, K Soon11, V Zmazek12, K M Mayre-Chilton6,13.
Abstract
Epidermolysis Bullosa (EB) is a group of rare genetic disorders resulting in skin fragility and other symptoms. Commissioned by DEBRA International and funded by DEBRA Norway, this evidence-bases guideline provides recommendations to optimise psychosocial wellbeing in EB.An international multidisciplinary panel of social and health care professionals (HCP) and people living with EB was formed. A systematic international literature review was conducted by the panel following the Scottish Intercollegiate Guidelines Network (SIGN) methodology. The resulting papers underwent systematic selection and critique processes. Included papers were allocated to 6 different outcome groups to allow data synthesis and exploration: quality of life, coping, family, wellbeing, access to HCP and pain. Based on the evidence in those papers, recommendations were made for individuals living with EB, family and caregivers and HCP working in the field.Few studies have investigated interventions and which factors lead to better outcomes, but general recommendations can be made. EB is a complex disease impacting enormously on every aspect of psychosocial life. People and families living with EB need access to multidisciplinary support, including psychological guidance, in order to improve quality of life and psychosocial wellbeing. Interventions should stimulate social participation to prevent isolation. People with EB and their families should be able to access a supportive network. HCP should be well supported and educated about the complexity of EB. They should work collaboratively with those around the individual with EB (e.g. schools, employers etc.) to provide psychosocial opportunity and care.Attention should be paid to the psychosocial impact of EB as well as physical needs. Directions for research are indicated.Entities:
Keywords: Epidermolysis bullosa; Family; Guideline; Professionals; Psychological; Psychosocial; Recommendations; Social
Mesh:
Year: 2019 PMID: 31186066 PMCID: PMC6560722 DOI: 10.1186/s13023-019-1086-5
Source DB: PubMed Journal: Orphanet J Rare Dis ISSN: 1750-1172 Impact factor: 4.123
Fig. 1Search terms and inclusion criteria
Fig. 2Translated Key search terms
Fig. 3Flow-chart to filter articles based on title and abstract
Fig. 4Flow of information through the evidence evaluation process
Fig. 5Overview evidence per outcome
Recommendations summary for the Psychosocial care of individuals living with EB
| Recommendations | Population | Grade strength | Quality of evidence | Quality of evidence | Key references |
|---|---|---|---|---|---|
| i. We strongly recommend easy access to psychosocial support to improve Quality of life (QoL) | |||||
A multidisciplinary approach in treating EB improves QoL for individuals with EB • Psychological support and close monitoring of EB improves QoL. • They facilitate participation in social activities. • Patients with all types of EB including EBS report a great impairment in QoL due to restrictions in physical and social activities. | ✓ Adults, children ( Unclear if adults, children or both ( Adults, children ( Review of inherited & autoimmune blistering diseases | B | 2++ | 1- 2+ 2+ 2- 1- | [ [ [ [ [ |
| ii. We strongly recommend psychosocial support to improve well-being | |||||
To promote self-efficacy and support around body image to aid psychological well-being • Having access to knowledge and resources about EB can help people have a greater role in managing their EB. This self-management can help improve well-being. • Improved self-efficacy and locus of control, as well as support around body-image could help to develop a more positive sense of well-being. For support during transition periods in life (school transitions, transition into adulthood) • Communication and education about EB to improve people’s understanding. • Support from families, EB healthcare professionals and DEBRA. | Review of inherited &autoimmune blistering diseases Adults ( Children 10–14 years old ( Young male adults (aged 21–35 years) with RDEB ( Observational report | C | 2+ | 1- 2+ 2+ 4 4 | [ [ [ [ [ |
| iii. We strongly recommend gaining access to psychosocial support for the whole family | |||||
People diagnosed with EB should be referred for psychosocial support as early as possible in childhood or in adulthood, if the person with EB wishes • To support the family unit. Encourage supportive network for the family, for example: • Education about EB for others • Provide access to DEBRA (or other EB support groups) | ✓ Children ( Children ( | C | 2- | 2- 2- 4 | [ [ [ |
| iv. We recommend psychosocial support to help with pain | |||||
Pain is present for most children and adults with EB (all types) with profound psychosocial impact: • Activity related pain can significantly affect psychosocial well-being and QoL (e.g. fear of/actual pain restricting social activities, affecting relationships with family and friends). • Treatment related pain can make managing EB harder and link to procedural anxiety. Adequate holistic pain management is essential as a focus for helping people with EB: • Following pain guidelines. • Offering approaches to help people with EB cope emotionally. • Help with managing the impact of pain and the interlinked cycle of pain and psychosocial challenges. | Adults, children( Adults ( Children; ( Adults ( Children/families ( Adults ( Unclear if adult/child ( EBS, JEB, DDEB, RDEB Best practice guideline Children ( Adult ( | C | 2- | 2+ 2- 2- 2- 2- 2+ 2+ ⇒ 2+ 3 | [ [ [ [ [ [ [ [ [ [ |
| v. We strongly recommend psychosocial support to help cope with living with EB | |||||
People with EB need support to cope with EB, and their ways of coping need to be supported by others: participation in social life needs to be supported • Such as at school, the community, friendships, employment. • Aid access to supportive networks. • Public education campaigns to help those around them to understand EB and their needs. Promote a sense of self-management of their EB • This can help bring a sense of control over certain aspects of the disease/treatment and pain. Build social skills and communication • Help in learning how to communicate about EB to others and within the family unit. | ✓ Children ( Children 10–14 years old ( Children ( EBS; JEB; DDEB; RDEB Children ( EBS; JEB; DDEB; RDEB | C | 2- | 2+ 2+ 2- 2- | [ [ [ [ |
| vi. We strongly recommend psychosocial support from a multidisciplinary Health Care Team | |||||
Encourage access to, and a collaborative ‘working together’ relationship with, an expert multi-disciplinary team of professionals. • Facilitate access to multidisciplinary professional support for medical and psychosocial care across the lifespan. • At both specialist centres and community services | ✓ Adults, children ( Children ( Children ( HCPs ( Adults ( Children and Adults ( Children ( Children ( | C | 2- | 1- 2+ 2+ 2+ 2- 2- 2- 2- 2- 2+ | [ [ [ [ [ [ [ [ [ [ |
| Key: EB: Epidermolysis Bullosa; RDEB: Recessive Dystrophic Epidermolysis Bullosa; JEB: Junctional Epidermolysis Bullosa; DDEB: Dominant Dystrophic Epidermolysis Bullosa; EBS: Epidermolysis Bullosa Simplex EBS-I: Localised form of EBS; KS Kindler Syndrome; QoL: quality of life; n: number of; α: gray literature; ⇒this is an EB guideline | |||||
| Grades | Descriptions in accordance to SIGN [ | ||||
| B | A body of evidence including studies rated as 2++, directly applicable to the target population, and demonstrating overall consistency of results; or Extrapolated evidence from studies rated as 1++ or 1+ | ||||
| C | A body of evidence including studies rated as 2+, directly applicable to the target population and demonstrating overall consistency of results; or Extrapolated evidence from studies rated as 2++ | ||||
| Ratings Descriptions in accordance to SIGN [ | |||||
| 1- | Meta-analyses, systematic reviews, or RCTs with a high risk of bias | ||||
| 2++ | High quality case control or cohort studies with a very low risk of confounding or bias and a high probability that the relationship is causal | ||||
| 2+ | Well conducted case control or cohort studies with a low risk of confounding or bias and a moderate probability that the relationship is causal | ||||
| 2- | Case control or cohort studies with a high risk of confounding or bias and a significant risk | ||||
| 3 | Non-analytic studies, e.g. case reports, case series | ||||
| 4 | Expert opinion | ||||
| ✔ Recommended best practice based on the clinical experience of the guideline development group [ | |||||
Recommendations summary for the Psychosocial care of Family and caregivers of people living with EB
| Recommendations | Population | Grade strength | Quality of evidence | Quality of evidence | Key references |
|---|---|---|---|---|---|
| i. We strongly recommend access to psychosocial family support to improve the family QoL | |||||
Early psychosocial support to improve • As caregivers QoL may also be impacted. • Psychological support and close monitoring helps. • Support is essential for family of palliative patients with EB. | Adults, children; 11 studies EBS; JEB; DDEB; RDEB Adults, children ( EBS; JEB; DDEB; RDEB; KS Children ( | B | 2+ | 1- 2+ 2- | [ [ [ |
| ii. We strongly recommend psychosocial support to improve the family well-being | |||||
Support for the • Home nursing can provide much needed relief and support for primary caregivers and could reduce the need for hospital admission. • Actively assist in seeking counselling before the family unit is irreparably destroyed. • Provide information about the nature, course and outcome of EB. • Provide training in the management of patient symptoms. • Access to Social media and face to face EB support groups might be beneficial for families. Promoting family well-being can help the family enhance their strong and positive influence for those living with EB • The way the family reacts to EB can be psychologically assimilated by the person with EB, particularly children. • Acceptance of the EB by the family is important and can make it more bearable for the patient. | Adults, children ( Children, Adults ( EBS; JEB; DDEB; RDEB Adults, children ( EBS; JEB; DDEB; RDEB; KS Adults, children ( Adult – personal experience | C | 2- | 2+ 2+ 2- 4 2+ 4 | [ [ [ [ [ [ |
| iii. We strongly recommend family counselling in order to prevent family breakdown | |||||
To help prevent the • Strengthen To prevent • Support in managing life with EB. To prevent • Specially provide support for single parents with a child living with EB. | Children, Adults ( EBS; JEB; DDEB; RDEB Adults, children ( Children ( EBS; JEB; DDEB; RDEB | C | 2- | 2+ 2+ 2- | [ [ [ |
Adults, children ( EBS; JEB; DDEB; RDEB Children ( Children, Young Adults; ( | 2- 2- 2- | [ [ [ | |||
Adults, children ( EBS; JEB; DDEB; RDEB; KS | 2- | [ | |||
| iv. We strongly recommend psychosocial support to help the whole family to cope with living with EB | |||||
Specialist home based psychosocial support for the • Help access counselling to promote the intra- • Access help to manage EB and economic burden. • Promote good relationships between the family • Provide a home care program for respite, or support handing over physical care to others. | Children ( EBS; JEB; DDEB; RDEB Adults, children ( EBS; JEB; DDEB; RDEB; KS Adults, children ( EBS; JEB; DDEB; RDEB Children ( EBS; JEB; DDEB; RDEB | C | 2- | 2+ 2- 2- 2- | [ [ [ [ |
| v. We recommend psychosocial support to reduce emotional burden during daily painful procedures | |||||
Psychosocial support needs for parents and family to reduce the emotional burden of caring for someone living with EB who has severe • Offer psychological support for caregivers. Parents/care givers can struggle with ‘causing pain’ due to dressing changes and wanting to protect their child from pain. This is very difficult emotionally for parents. • Pain can negatively affect relationships within the family and with friends. Help optimise pain management techniques. • Parents/carers can find it difficult to see people in severe pain. Aid access to respite, independent carers and promote independence with dressings. | ✓ Children ( EBS; JEB; DDEB; RDEB Adults, children; ( Adult ( | C | 2- | 2+ 2- 2- | [ [ [ |
| vi. We strongly recommend easy access to a multidisciplinary expert team for the whole family | |||||
Provide access to recognised expert support and training for the whole family • Provide appropriate treatment and training or refer to national EB experts. • Referring to with the DEBRA or EB support network may help. | Adults, children; 11 studies EBS; JEB; DDEB; RDEB Adults, children ( Children ( EBS; JEB; DDEB; RDEB Children ( EBS; JEB; DDEB; RDEB Adult ( | C | 2- | 1- 2+ 2+ 2+ 4 | [ [ [ [ [ |
| Key: EB: Epidermolysis Bullosa; RDEB: Recessive Dystrophic Epidermolysis Bullosa; JEB: Junctional Epidermolysis Bullosa; DDEB: Dominant Dystrophic Epidermolysis Bullosa; EBS: Epidermolysis Bullosa Simplex EBS-I: Localised form of EBS; KS Kindler Syndrome; QoL: quality of life; n: number of; α: gray literature; ⇒this is an EB guideline | |||||
| Grades | Descriptions in accordance to SIGN [ | ||||
| B | A body of evidence including studies rated as 2++, directly applicable to the target population, and demonstrating overall consistency of results; or Extrapolated evidence from studies rated as 1++ or 1+ | ||||
| C | A body of evidence including studies rated as 2+, directly applicable to the target population and demonstrating overall consistency of results; or Extrapolated evidence from studies rated as 2++ | ||||
| Ratings Descriptions in accordance to SIGN [ | |||||
| 1- | Meta-analyses, systematic reviews, or RCTs with a high risk of bias | ||||
| 2+ | Well conducted case control or cohort studies with a low risk of confounding or bias and a moderate probability that the relationship is causal | ||||
| 2- | Case control or cohort studies with a high risk of confounding or bias and a significant risk | ||||
| 4- | Expert opinion | ||||
| ✔ Recommended best practice based on the clinical experience of the guideline development group [ | |||||
Psychosocial management recommendations for professional working with EB
| Recommendations | Population | Grade strength | Quality of evidence | Quality of evidence | Key references |
|---|---|---|---|---|---|
| i. We strongly recommend psychosocial expertise to help people to cope with living with EB | |||||
Access to EB specialised care • Nurturing a good relationship between professionals, family and person with EB • Training for non-EB professionals | Children 10–14 years old ( Children ( EBS; JEB; DDEB; RDEB Children ( EBS; JEB; DDEB; RDEB | C | 2- | 2+ 2- 2- | [ [ [ |
| ii. We strongly recommend a collaborative patient-professional relationship | |||||
| • Training for professionals in working collaboratively with patients. | HCPs ( | C | 2- | 2- | [ |
| iii. We strongly recommend offering support for professionals working in EB | |||||
• To promote well-being for the healthcare professional • Emotional support is necessary: Personal support but also on an organisational level. • Importance of Professionals self-care: awareness, support to do this and access to clinical supervision. • Important to not work in isolation: the need to link in with an MDT and to feel equipped through information and education to help with psychosocial needs. | Key Stakeholders ( Key Stakeholders ( Adults ( | C | 2- | 2- 2- 2- | [ [ [ |
| Key: EB: Epidermolysis Bullosa; RDEB: Recessive Dystrophic Epidermolysis Bullosa; JEB: Junctional Epidermolysis Bullosa; DDEB: Dominant Dystrophic Epidermolysis Bullosa; EBS: Epidermolysis Bullosa Simplex EBS-I: Localised form of EBS; KS Kindler Syndrome; HCPs: Health care professionals; MDT: multidisciplinary team; n: number of; α: gray literature; ⇒this is an EB guideline | |||||
| Grades | Descriptions in accordance to SIGN [ | ||||
| C | A body of evidence including studies rated as 2+, directly applicable to the target population and demonstrating overall consistency of results; or Extrapolated evidence from studies rated as 2++ | ||||
| Ratings | Descriptions in accordance to SIGN [ | ||||
| 2- | Case control or cohort studies with a high risk of confounding or bias and a significant risk | ||||
Fig. 6Areas of research for the individual, family, caregivers and professionals
| Recommendation Summary | Grade strength | Quality of evidence | Key references |
|---|---|---|---|
| A. Psychosocial care for individuals living with EB | |||
| We strongly recommend easy access to psychosocial support to improve QoL | B✓ | 2++ | [ |
| We strongly recommend psychosocial support to improve well-being | C | 2+ | [ |
| We strongly recommend gaining access to psychosocial support for the whole family | C✓ | 2- | [ |
| We recommend psychosocial support to help with pain | C | 2- | [ |
| We strongly recommend psychosocial support to help coping with EB | C✓ | 2- | [ |
| We strongly recommend psychosocial support from a multidisciplinary Health Care Team | C✓ | 2- | [ |
| B. Psychosocial care for family and care givers of people with EB | |||
| We strongly recommend access to psychosocial family support to improve the family QoL | B | 2+ | [ |
| We strongly recommend psychosocial support to improve family well-being | C | 2- | [ |
| We strongly recommend family counselling in order to prevent family breakdown | C✓ | 2- | [ |
| We strongly recommend psychosocial support to help the whole family to cope with living with EB | C | 2- | [ |
| We recommend psychosocial support to reduce emotional burden during daily painful procedures | C | 2- | [ |
| We strongly recommend easy access to a multidisciplinary expert team for the whole family | C | 2- | [ |
| C. Self-care for professionals working with those affected by EB | |||
| We strongly recommend psychosocial expertise to help people to cope with living with EB | C | 2- | [ |
| We strongly recommend a collaborative patient-professional relationship | C | 2- | [ |
| We strongly recommend offering support for professionals working in EB | C | 2- | [ |
| KEY: EB: Epidermolysis Bullosa; QoL: quality of life; n: number of participants; α gray literature | |||
| Grades | Descriptions in accordance to SIGN [ | ||
| B | A body of evidence including studies rated as 2++, directly applicable to the target population, and demonstrating overall consistency of results; or Extrapolated evidence from studies rated as 1++ or 1+ | ||
| C | A body of evidence including studies rated as 2+, directly applicable to the target population and demonstrating overall consistency of results; or Extrapolated evidence from studies rated as 2++ | ||
| Ratings | Descriptions in accordance to SIGN [ | ||
| 2++ | High quality case control or cohort studies with a very low risk of confounding or bias and a high probability that the relationship is causal | ||
| 2+ | Well conducted case control or cohort studies with a low risk of confounding or bias and a moderate probability that the relationship is causal | ||
| 2- | Case control or cohort studies with a high risk of confounding or bias and a significant risk | ||
| ✔ Recommended best practice based on the clinical experience of the guideline development group [ | |||